Wang QQ, Yan X, Wang TT, Zeng LH (2023) Glucagon-Like Peptide 1 Receptor Agonists in Alzheimers Disease
Standard good laboratory practice diet and fresh water were provided ad libitum
However, montelukast carries mood-related warnings from the FDA
A study conducted in 2015 looked at the effects of Liraglutide on weight loss in adults who were overweight or obese
In January 2026, Amylyx Pharmaceuticals selected AMX0318, a long-acting GLP-1 receptor antagonist, as a development candidate for PBH and other rare diseases
In particular, tell your provider if you have or had a past history of: Type 1 or type 2 diabetes Thyroid cancer Gastrointestinal disease Pancreatitis Kidney disease Diabetic retinopathy Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding